India Approves Two COVID-19 Vaccines: Oxford-Serum Institute's Covishield & Bharat Biotech's Covaxin Receives Emergency Approval From DCGI

Covid Vaccine : DCGI Approval Letter | Covaxin | Covishield | Oneindia Telugu

India Approves 2 COVID-19 Vaccines: Covaxin, Covishield Vaccines 110% सुरक्षित

Covishield of Serum Institute,Covaxin of Bharat Biotech get DCGI approval as coronavirus vaccines_D4-H-21

Drugs Controller General of India (DCGI) grants conditional market approval for Covishield &Covaxin

Corona Vaccine: Covishield, Covaxin अब अस्पताल में होगी उपलब्ध, DCGI से मिली अनुमति | वनइंडिया हिंदी

Covid-19 Vaccine: DCGI ने Study को दी मंजूरी, Covishield और Covaxin होंगे Mix | वनइंडिया हिंदी

Covid vaccine for children, DCGI gives approval to Covaxin

Covaxin, Covishield granted regular market approval in India

Covishield, Covaxin Get Panel's Recommendation For Regular Market Approval

Special Story | Prices Of Covishield & Covaxin Vaccines May Reduce

COVID 19 ।Covaxin, Covishield Vaccines Likely To Cost Rs 275 After Market Nod

Covishield, Covaxin Covid-19 vaccines to be very soon available in India: Harsh Vardhan

Covishield vs Covaxin: A comparison of the two Covid-19 vaccines approved in India

Centre reveals cost of Covishield and Covaxin vaccines

Top Odisha Health Official’s Clarification On Mixing Covaxin and Covishield Vaccines

Covishield, Covaxin vaccines will be available in India soon: Health minister Harsh Vardhan

India approves Covishield, Covaxin vaccines: Road to Covid-free India?

India Approves Two COVID-19 Vaccines: Covishield ও Covaxin ব্যবহারে অনুমোদন, বিরোধীদের তোপ

DCGI grants approval to vaccines of Serum Institute of India, Bharat Biotech

Bharat Biotech’s Covaxin safe for children of 2to18 years says Lancet Journal Oneindia News*News

Covaxin: सीरियन हैमस्टर मॉडल पर हुई स्टडी में खुलासा, ये वैक्सीन है शानदार

COVAXIN BOOSTER DOSE: EFFECTIVE AGAINST OMICRON AND DELTA VARIANT| OneIndia News* News

Bharat Biotech: Covaxin booster dose effective against neutralising Omicron and Delta variants of COVID-19

India sends Covaxin to Taliban-ruled Afghanistan

Covaxin ‘highly efficacious’ with 77.8% efficacy

Election Code _ CP CV Anand Orders Arms License Holders Deposit Weapons In Police Station _ V6 News (2)

Farmers Protest Against Govt Over Paddy Sugarcane MSP At Chennai _ V6 News (1)

BRS Today : CM KCR Meet With Minister Harish Rao | MLA Rajaiah Comments | V6 News

Congress Today : Congress BC Leaders Protest | Ponguleti Srinivas Reddy | V6 News

BJP Today Kishan Reddy Fires On BRS Party MP Laxman On Politics V6 News

YS Sharmila To Contest Alone Without Congress Alliance _ V6 Teenmaar

Indian government bans Common Cold and Flu Syrups for kids below 4 years | Oneindia News

Special Story | DCGI Approves Corbevax For 5-12 Year Children, Covaxin For 6-12 Years

Covaxin gets DCGI nod for 6-12 age group, Corbevax for 5-12-year-olds

Covaxin Gets DCGI Nod For Restricted Emergency Use In Children Aged 6-12 Years

DCGI granted emergency use permission to Single-dose Sputnik Light COVID19 vaccine in India _Tv9News

DCGI approves trials for nasal Covid booster in India